Atlas Trials

Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia

Clinical trial NCT00391560 · COMPLETED

Trial details

NCT number
NCT00391560
Sponsor
AEterna Zentaris
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2006-10-01
Primary completion
2010-10-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.